Literature DB >> 20607043

Epidemiology and survival of patients with hepatocellular carcinoma in Southern Germany.

Gabriele Kirchner, Georgi Kirovski, Alexandra Hebestreit, Jürgen Schölmerich, Hans Jürgen Schlitt, Oliver Stoeltzing, Claus Hellerbrand.   

Abstract

Hepatocellular carcinoma (HCC) belongs to the most frequent tumors worldwide with an incidence still rising. Patients with cirrhosis are at the highest risk for cancerogenesis and are candidates for surveillance, and here, as well as for the choice of potential forms of treatment, identification of suitable parameters for estimating the prognosis is of high clinical importance. The aim of this study was to describe the etiology of underlying liver disease and to identify predictors of survival in a large single center cohort of HCC patients in Southern Germany. Clinicopathologi-cal characteristics and survival rates of 458 patients (83.6% male; mean age: 62.5+/-11.2 years) consecutively admitted to a University Hospital between 1994 and 2008 were retrospectively analyzed. The results indicate that chronic alcohol abuse was the most common risk factor (57.2%), followed by infection with hepatitis B and C viruses (HBV: 10.9% and HCV: 20.5%). Overall median survival was 19.0 months, and higher OKUDA, CHILD and CLIP scores correlated negatively with prognosis. Of these, only the CLIP Score was an independent predictor in multivariate analysis. We conclude that chronic alcohol abuse is frequently associated with HCC in low hepatitis virus endemic areas, such as Germany. Our study suggests the CLIP score as a valuable prognostic marker for patients' survival, particularly of patients with alcohol related HCC.

Entities:  

Keywords:  CLIP score; HCC; epidemiology; hepatocellular carcinoma; survival

Year:  2010        PMID: 20607043      PMCID: PMC2894652     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  31 in total

1.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

2.  Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre.

Authors:  A Grieco; M Pompili; G Caminiti; L Miele; M Covino; B Alfei; G L Rapaccini; G Gasbarrini
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

3.  Hepatocellular carcinoma in Sweden: its association with viral hepatitis, especially with hepatitis C viral genotypes.

Authors:  A Widell; H Verbaan; R Wejstål; J Kaczynski; K Kidd-Ljunggren; S Wallerstedt
Journal:  Scand J Infect Dis       Date:  2000

4.  [The influence of regional differences in drinking style on hazardous use, excessive drinking, abuse and dependence].

Authors:  L Kraus; R Augustin; K Bloomfield; A Reese
Journal:  Gesundheitswesen       Date:  2001-12

Review 5.  Environmental factors and risk for hepatocellular carcinoma.

Authors:  Mimi C Yu; Jian-Min Yuan
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

6.  Hepatocellular carcinoma in Central Europe: prognostic features and survival.

Authors:  M Schöniger-Hekele; C Müller; M Kutilek; C Oesterreicher; P Ferenci; A Gangl
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

7.  Prevalence of markers of hepatitis B in the adult German population.

Authors:  W Jilg; B Hottenträger; K Weinberger; K Schlottmann; E Frick; A Holstege; J Schölmerich; K D Palitzsch
Journal:  J Med Virol       Date:  2001-02       Impact factor: 2.327

Review 8.  Etiological factor of hepatocellular carcinoma in Italy.

Authors:  T Stroffolini
Journal:  Minerva Gastroenterol Dietol       Date:  2005-03

9.  Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan.

Authors:  Y Shiratori; S Shiina; M Imamura; N Kato; F Kanai; T Okudaira; T Teratani; G Tohgo; N Toda; M Ohashi
Journal:  Hepatology       Date:  1995-10       Impact factor: 17.425

10.  Comparison of surgical outcomes for small hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a Chinese experience.

Authors:  Qiang Li; Huikai Li; Yu Qin; P Peter Wang; Xishan Hao
Journal:  J Gastroenterol Hepatol       Date:  2007-11       Impact factor: 4.029

View more
  11 in total

1.  Clinical characteristics of patients with hepatocellular carcinoma in Austria - is there a need for a structured screening program?

Authors:  Florian Hucke; Wolfgang Sieghart; Maximilian Schöniger-Hekele; Markus Peck-Radosavljevic; Christian Müller
Journal:  Wien Klin Wochenschr       Date:  2011-07-29       Impact factor: 1.704

2.  Delayed Diagnosis of HCC with Chronic Alcoholic Liver Disease.

Authors:  Kerstin Schütte; Jan Bornschein; Stefan Kahl; Ricarda Seidensticker; Jörg Arend; Jens Ricke; Peter Malfertheiner
Journal:  Liver Cancer       Date:  2012-11       Impact factor: 11.740

3.  Comparison of the clinical characteristics and survival between Uyghur patients with hepatitis virus-related and non-B, non-C hepatocellular carcinoma in Xinjiang, China.

Authors:  Lei Xiao; Rui-Li Zhang; Hua Zhang; Aisiker Tulahong; Yue-Fen Zhang; Hao Wen; Yong-Xing Bao
Journal:  Chin J Cancer Res       Date:  2015-06       Impact factor: 5.087

4.  Gadoxetate acid-enhanced MRI of hepatocellular carcinoma in a c-myc/TGFα transgenic mouse model including signal intensity and fat content: initial experience.

Authors:  Huedayi Korkusuz; Lea Knau; Wolfgang Kromen; Frank Huebner; Renate Hammerstingl; Sebastian Lindemayr; Verena Bihrer; Albrecht Piiper; Thomas J Vogl
Journal:  Cancer Imaging       Date:  2012-03-07       Impact factor: 3.909

5.  Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma.

Authors:  Arndt Weinmann; Yvonne Alt; Sandra Koch; Carina Nelles; Christoph Düber; Hauke Lang; Gerd Otto; Tim Zimmermann; Jens U Marquardt; Peter R Galle; Marcus A Wörns; Jörn M Schattenberg
Journal:  BMC Cancer       Date:  2015-04-01       Impact factor: 4.430

Review 6.  Long Noncoding RNAs as a Key Player in Hepatocellular Carcinoma.

Authors:  Mrigaya Mehra; Ranjit Chauhan
Journal:  Biomark Cancer       Date:  2017-11-02

7.  Validation of insulin-like growth factor-1 as a prognostic parameter in patients with hepatocellular carcinoma in a European cohort.

Authors:  Yvonne Huber; Franziska Bierling; Christian Labenz; Sandra Koch; Irene Schmidtmann; Roman Kloeckner; Sebastian Schotten; Tobias Huber; Hauke Lang; Marcus A Woerns; Peter R Galle; Arndt Weinmann; Julia Weinmann-Menke
Journal:  BMC Cancer       Date:  2018-07-31       Impact factor: 4.430

8.  Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohort.

Authors:  Mark op den Winkel; Dorothea Nagel; Julia Sappl; Philip op den Winkel; Rolf Lamerz; Christoph J Zech; Gundula Straub; Thomas Nickel; Markus Rentsch; Petra Stieber; Burkhard Göke; Frank T Kolligs
Journal:  PLoS One       Date:  2012-10-05       Impact factor: 3.240

9.  Clinical, Epidemiological and Histopathological Aspects in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation

Authors:  Nathalia Martines Tunissiolli; Márcia Maria Urbanin Castanhole-Nunes; Érika Cristina Pavarino; Renato Ferreira da Silva; Rita de Cássia Martins Alves da Silva; Eny Maria Goloni-Bertollo
Journal:  Asian Pac J Cancer Prev       Date:  2018-10-26

10.  The epidemiology of Hepatitis B, C and D in Germany: A scoping review.

Authors:  Gyde Steffen; Ida Sperle; Siv Aina Leendertz; Navina Sarma; Sandra Beermann; Roma Thamm; Viviane Bremer; Ruth Zimmermann; Sandra Dudareva
Journal:  PLoS One       Date:  2020-03-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.